Baricitinib(CAS: 1187594-09-7)

Baricitinib (CAS: 1187594-09-7) is a selective Janus kinase (JAK) inhibitor with the chemical formula C19H23N5O3S. It is a white crystalline powder, known for its anti-inflammatory and immunomodulatory properties. Baricitinib works by blocking specific cytokine signaling pathways, making it effective in treating autoimmune and inflammatory diseases.

Baricitinib (CAS: 1187594-09-7) is primarily used as a medication for conditions like rheumatoid arthritis and psoriatic arthritis, where it inhibits JAK enzymes to reduce inflammation. It also has pharmaceutical applications in treating other autoimmune disorders. In research, Baricitinib is studied for its potential in modulating immune responses and exploring new therapeutic uses.

Baricitinib (CAS: 1187594-09-7) is approved by regulatory agencies like the FDA and EMA for specific medical uses. While generally safe when used as directed, it may cause side effects such as infections, gastrointestinal issues, or increased bleeding risk. Proper handling, including PPE and ventilation, is recommended for laboratory use to ensure safety standards are met.

Baricitinib (CAS: 1187594-09-7) should be stored in a cool, dry place at room temperature (20-25°C), away from light and moisture. It requires airtight containers and desiccated conditions to maintain stability. Avoid exposure to heat or humidity to prevent degradation of the compound.